Riskpilot← Back to searchSign inGet full accessBIOTECHNICS DANMARK A/S
A/SActiveCVR 29822034Axel Heides Vej 2Engineering activities and related technical consultancy · NACE 7112Est. 20094 employeeswww.biotechnics.dk
Revenue 2024
DKK 2M
+12% vs 2023
EBITDA margin
0.8%
-95% vs 2023
Equity ratio
38.4%
Financial strength
Net profit 2024
DKK -22K
-111% vs 2023
| Revenue | DKK 2M | +12% |
| EBITDA | DKK 15K | -95% |
| Net profit | DKK -22K | -111% |
| Total assets | DKK 1,5M | +4% |
| Equity | DKK 578K | -27% |
| Employees | 4 | — |
Legal name
BIOTECHNICS DANMARK A/S
CVR number
29822034
Legal form
Aktieselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
9. juli 2009
Share capital
DKK 600.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion i forening med bestyrelsesformanden.
Company purpose
Selskabets formål er at drive handels- og servicevirksomhed. Selskabet kan efter bestyrelsens beslutning drive anden virksomhed, der står i naturlig forbindelse med det nævnte hovedformål
Address
Axel Heides Vej 2
Phone
+4570777880
Email
info@biotechnics.dk
Website
www.biotechnics.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 182 | — | — | — | -78 | -277 | 150 | 200 | 146 | 89 | 1.497 | 1.783 | 2.005 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -32 | -36 | -51 | -142 | -770 | -1.465 | -1.990 |
| EBITDA | 182 | 0 | 0 | 0 | -78 | -277 | 117 | 165 | 95 | -53 | 727 | 318 | 15 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -22 | -1 | -0 | -0 |
| EBIT | 182 | 0 | 0 | 0 | -78 | -277 | 117 | 165 | 94 | -75 | 726 | 318 | 15 |
| Net financials | -22 | 0 | 0 | 0 | 4 | 2 | -0 | -3 | -13 | -120 | -96 | -31 | -16 |
| Profit before tax | 204 | 0 | 0 | 0 | -74 | -276 | 117 | 162 | 81 | -195 | 629 | 287 | -1 |
| Tax | 50 | -0 | -0 | -0 | -25 | -52 | 27 | 36 | 16 | -18 | 167 | 91 | 21 |
| Net profit | 153 | 0 | 0 | 0 | -49 | -223 | 91 | 126 | 64 | -178 | 462 | 197 | -22 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 362 | 0 | 0 | 0 | 452 | 410 | 414 | 841 | 838 | 616 | 1.508 | 1.444 | 1.506 |
| Equity | 460 | 0 | 0 | 0 | 413 | 190 | 281 | 406 | 471 | 293 | 755 | 797 | 578 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 140 | 43 | 0 | 0 | 0 |
| Short-term debt | -821 | 0 | 0 | 0 | 39 | 220 | 133 | 435 | 227 | 279 | 753 | 647 | 928 |
| Total debt | -821 | 0 | 0 | 0 | 39 | 220 | 133 | 435 | 367 | 323 | 753 | 647 | 928 |
EBITDA margin
0.8%
This company
15.8%
Market median
-95% vs market
20122024
Equity ratio
38.4%
This company
38.2%
Market median
+1% vs market
20122024
Return on equity
-3.7%
This company
18.4%
Market median
-120% vs market
20122024
Net profit margin
-1.1%
This company
8.1%
Market median
-114% vs market
20122024
Asset turnover
1.33×
This company
1.12×
Market median
+19% vs market
20122024
Debt / equity
1.60×
This company
0.62×
Market median
-158% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JD Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
JJ Management | Management | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2009 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2009 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Biosystems Holding ApS | Company | 100.0% | 100.0% | 2020 |
PALM investment ApS | Company | 100.0% | 100.0% | 2019 |
| Individual | 33.3% | 33.3% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Biosystems Holding ApS
BIOTECHNICS DANMARK A/S Board members of BIOTECHNICS DANMARK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jakob Dige | Chief Executive Officer | 0 companies |
| Jonas Jacob Husmer | Management | 0 companies |
| Flemming Heegaard | Chairman | 0 companies |
| Philip Broberg Falk | Board of Directors | 0 companies |
| Martin Lavesen | Board of Directors | 0 companies |
| Jens Peter Hjørnholm Sørensen | Chairman | 0 companies |
| Philip Carsten Filipsen | Board of Directors | 0 companies |
| Allan Pettersson | Board of Directors | 0 companies |
| Leif Peter Dige | Chairman | 0 companies |